The December conference of the American Society of Hematology (ASH, Washington) in San Diego was marked by the continued emphasis on diagnostic technologies as the core of a highly clinical and biological meeting. Few meetings across the clinical spectrum address biology, biochemistry, and biomarkers in a way that annual meetings at ASH in hematology, and at the American Society of Clinical Oncology (ASCO, Alexandria, Virginia) in solid oncology, tend to. Read More
While few venture capitalists and venture-backed med-tech CEOs were sad to see 2011 come to an end, the outlook for 2012 might be even less optimistic in some respects, according to this year's Venture View predictions survey. (Medical Device Daily) Read More
